Publications by authors named "Clive Taylor"

Claim this Profile
F
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Federico Rojo, Clive R Taylor, Carlos Barrios, Laura Torrecillas, Manuel Ruiz-Borrego

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemistry Should Be Regulated as an Assay.
Barbarajean Magnani, Clive R Taylor

Arch Pathol Lab Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "Antigen Retrieval Immunohistochemistry: Past, Present, and Future".
Clive R Taylor, Shan-Rong Shi

J Histochem Cytochem· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Consortium for Analytic Standardization in Immunohistochemistry.
Steven A Bogen, David J Dabbs, Keith D Miller, Søren Nielsen, Suzanne C Parry, Clive R Taylor

Arch Pathol Lab Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Dimensions of Antigen Retrieval Technique: 28 Years of Development, Practice, and Expansion.
Shan-Rong Shi, Yan Shi, Clive R Taylor, Jiang Gu

Appl Immunohistochem Mol Morphol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milestones in Immunohistochemistry and Molecular Morphology.
Clive R Taylor

Appl Immunohistochem Mol Morphol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Mustafa I Jaber, Bing Song, Clive Taylor, Charles J Vaske, Stephen C Benz

Breast Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer.
Clive R Taylor, Anagha P Jadhav, Abhi Gholap, Gurunath Kamble, Jiaoti Huang

Appl Immunohistochem Mol Morphol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemistry: Growing Pains, From a Stain to an Assay.
Clive R Taylor

Appl Immunohistochem Mol Morphol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The International Society for Immunohistochemistry and Molecular Morphology (ISIMM).
Clive R Taylor

Appl Immunohistochem Mol Morphol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study).
Sanjay Mukhopadhyay, Michael D Feldman, Esther Abels, Raheela Ashfaq, Senda Beltaifa, Clive R Taylor

Am J Surg Pathol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma.
Therese Phillips, Molly M Millett, Xiaoling Zhang, Malinka Jansson, Rachel Cleveland, Clive Taylor

Appl Immunohistochem Mol Morphol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Audit of Failed Immunohistochemical Slides in a Clinical Laboratory: The Role of On-Slide Controls.
Carol C Cheung, Clive R Taylor, Emina E Torlakovic

Appl Immunohistochem Mol Morphol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of RANK and RANK Ligand in Normal Human Tissues as Determined by an Optimized Immunohistochemical Method.
Clive R Taylor, Daniel Branstetter, Edward Manna, William C Dougall, Jeanine Bussiere

Appl Immunohistochem Mol Morphol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved and Standardized Approaches to Selection of Control Materials From ISIMM: Announcing a Workshop at the Annual ASCP Meeting, September 6-7, 2017, Sponsored by the International Society for Immunohistochemistry and Molecular Morphology.
Clive R Taylor

Appl Immunohistochem Mol Morphol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Control in Modern Immunohistochemistry: Real-time Performance Characteristics and Quality Control of Important Widely Used Antibodies.
Clive R Taylor

Appl Immunohistochem Mol Morphol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry.
Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, Glenn D Francis, Regan Fulton, Clive R Taylor

Appl Immunohistochem Mol Morphol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.
Emina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, Glenn D Francis, Clive R Taylor

Appl Immunohistochem Mol Morphol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.
Emina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, Glenn D Francis, Clive R Taylor

Appl Immunohistochem Mol Morphol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Assessment for Targeted Therapy Testing in Cancer: Urgent Need For Realistic Economic and Practice Expectations.
Hadi Yaziji, Clive R Taylor

Appl Immunohistochem Mol Morphol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers.
Carol C Cheung, Corrado D'Arrigo, Manfred Dietel, Glenn D Francis, C Blake Gilks, Clive R Taylor

Appl Immunohistochem Mol Morphol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Jeff Johnson, Michael Choi, Farnaz Dadmanesh, Bingchen Han, Ying Qu, Clive Taylor

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HistoMosaic Detecting KRAS G12V Mutation Across Colorectal Cancer Tissue Slices through in Situ PCR.
Christopher B Raub, Chen-Chung Lee, Darryl Shibata, Clive Taylor, Emil Kartalov

Anal Chem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting controls under control: the time is now for immunohistochemistry.
Emina Emilia Torlakovic, Søren Nielsen, Mogens Vyberg, Clive R Taylor

J Clin Pathol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.
Therese Phillips, Pauline Simmons, Hector D Inzunza, John Cogswell, James Novotny, Clive Taylor

Appl Immunohistochem Mol Morphol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis